Common Contracts
1 similar License Agreement contracts
February 2, 2021License Agreement • December 22nd, 2023
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
